Cash And Equivalent Zmiana Data
AbbVie USD 13.29B 4.53B 2023-09
ALKERMES USD 647.71M 18.08M 2023-09
Amgen USD 10.94B 23.8B 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Bausch Health Companies USD 760M 181M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Cara Therapeutics USD 62.88M 4.63M 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Merck USD 8.6B 2.94B 2023-09
Pacira USD 153.3M 54.18M 2023-12
Perrigo USD 598.3M 43.1M 2023-09
Pfizer USD 3.15B 516M 2023-09
Prestige Brands USD 63.61M 3.55M 2023-12
Revance Therapeutics USD 179.32M 38.08M 2023-09
Supernus Pharmaceuticals USD 75.05M 19.93M 2023-12
Takeda JPY 318.05B 1.67B 2023-09
Xeris Pharmaceuticals USD 46.14M 27K 2023-09
Zoetis USD 2.04B 288M 2023-12



Horizon Pharma Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.